Page last updated: 2024-08-17

desoxycorticosterone acetate and transforming growth factor beta

desoxycorticosterone acetate has been researched along with transforming growth factor beta in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Hu, HL; Huang, XY; Liu, H; Liu, M; Qiao, Z; Sun, Y; Tang, W; Wang, XJ; Wang, ZY; Wu, JC; Yi, F; Zhan, P; Zhang, T; Zhang, Y; Zhu, JH1
Honda, H; Kato, T; Koiwa, F; Mizobuchi, M; Ogata, H; Saito, T1

Other Studies

2 other study(ies) available for desoxycorticosterone acetate and transforming growth factor beta

ArticleYear
GPR97 deficiency ameliorates renal interstitial fibrosis in mouse hypertensive nephropathy.
    Acta pharmacologica Sinica, 2023, Volume: 44, Issue:6

    Topics: Animals; Desoxycorticosterone Acetate; Fibrosis; Hypertension; Hypertension, Renal; Kidney; Mice; Transforming Growth Factor beta

2023
Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension.
    Laboratory investigation; a journal of technical methods and pathology, 2023, Volume: 103, Issue:1

    Topics: Animals; Blood Pressure; Calcitriol; Desoxycorticosterone Acetate; Fibroblast Growth Factor-23; Fibrosis; Heart Failure; Hypertension; Male; Mice; Renal Insufficiency, Chronic; Transforming Growth Factor beta; Transforming Growth Factors

2023